Cargando…
Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells
PURPOSE: Cisplatin-based chemotherapy is the first line treatment for several cancers including bladder cancer (BC). Autophagy induction has been implied to contribute to cisplatin resistance in ovarian cancer; and a high basal level of autophagy has been demonstrated in human bladder tumors. Theref...
Autores principales: | Lin, Ji-Fan, Lin, Yi-Chia, Tsai, Te-Fu, Chen, Hung-En, Chou, Kuang-Yu, Hwang, Thomas I-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439993/ https://www.ncbi.nlm.nih.gov/pubmed/28553083 http://dx.doi.org/10.2147/DDDT.S126464 |
Ejemplares similares
-
Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway
por: Tsai, Te-Fu, et al.
Publicado: (2019) -
Autophagy inhibition enhances RAD001-induced cytotoxicity in human bladder cancer cells
por: Lin, Ji-Fan, et al.
Publicado: (2016) -
Hsa-miR-30a-3p overcomes the acquired protective autophagy of bladder cancer in chemotherapy and suppresses tumor growth and muscle invasion
por: Hwang, Thomas I-Sheng, et al.
Publicado: (2022) -
Correction: Hsa-miR-30a-3p overcomes the acquired protective autophagy of bladder cancer in chemotherapy and suppresses tumor growth and muscle invasion
por: Hwang, Thomas I-Sheng, et al.
Publicado: (2022) -
miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells
por: Tsai, Te-Fu, et al.
Publicado: (2018)